ClearOne, Inc. (DE) Common Stock

Go to ClearOne, Inc. (DE) Common Stock Website

$4.73

-0.03 (-0.63%)
Live
Previous Close

$4.76

Day Range

$4.7 - $4.91

Previous Day Range

$4.58 - $4.93

Market Cap

$7.9 million USD

Day Vol.

15141

Previous Day Vol.

12389

Currency

USD

Primary Exchange

Nasdaq

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial produ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents. Fastenal shares dipped 6.7% to $69.73 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Rallybio Corporation (NASDAQ: RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rent the Runway, Inc. (NASDAQ: RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance. Eliem Therapeutics, Inc. (NASDAQ: ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement. Akanda Corp. (NASDAQ: AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company. Candel Therapeutics, Inc. (NASDAQ: CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof ...

Related tickers: APVO, ELYM, GL, SPRC, ICCT, AKAN, ACOR, LOVE, SLNA, CLRO, VERB, GVH, FAST, ENLV, GYRE, RENT, JFU, SUUN, KMX, RCEL, WD, AIH, ELVN, NKLA, ALPN, STEP, NRIX, MRIN, WNW, ESPR, JANX, VBIV, NYXH, GCT, CADL, ANAB, RLYB.

Read Full Article

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21. Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report   Leading and Lagging Sectors   Real estate shares rose by 0.6% on Thursday. In trading on Thursday, financial shares fell by 0.1%.   Top Headline   Producer prices in the U.S. rose 0.2% month-over-month in March compared to a 0.6% gain in February. However, analysts were expecting a gain of 0.3%.   Equities Trading UP   Rallybio Corporation (NASDAQ: RLYB) shares shot up 95% to $3.1793 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Shares of Eliem Therapeutics, Inc. (NASDAQ: ELYM) got a boost, ...

Related tickers: CLRO, RENT, APVO, ENLV, RLYB, ELYM.

Read Full Article
Trending Tickers

Please sign in to view